Exhibit 32(a)


            CERTIFICATION OF CHIEF EXECUTIVE OFFICER
               PURSUANT TO 18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In  connection  with  the  IGENE Biotechnology,  Inc.  (the
"Company") Quarterly Report on Form 10-QSB/A for the period ended
September  30,  2004, as filed with the Securities  and  Exchange
Commission on the date hereof (the "Report"), I, Stephen F.  Hiu,
President  of the Company, certify pursuant to 18 U.S.C.  Section
1350,  as  adopted pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge:

          (1). The Report fully complies with the requirements of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934, as amended; and

          (2).  The  information contained in the  Report  fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Company.


Date: September 29, 2005        By: /s/STEPHEN F. HIU
                                    _____________________________
                                       STEPHEN F. HIU
                                       President



A signed original of this written statement required by Section
906 has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission
or its staff upon request.